Quantiphi Recognized on DataTech50 List for Second Consecutive Year for Leadership in Data Management Solutions
The recognition reaffirms Quantiphi's continued excellence in delivering AI-powered data management solutions to financial services enterprises worldwide.
MARLBOROUGH, Mass., May 21, 2025 /PRNewswire/ -- Quantiphi, an award-winning AI-first digital engineering company, today announced it has been included, for the second year, in FinTech Global's DataTech50 list - an exclusive ranking spotlighting the world's 50 most innovative technology companies that provide advanced data management solutions for the financial services sector.
The DataTech50 recognition highlights Quantiphi's consistent leadership and innovation in empowering banks, insurers and financial institutions to modernize data platforms, strengthen governance and unlock actionable insights through AI and machine learning.
Quantiphi Global Head of Financial Services and Insurance, Bhaskar Kalita, said the back-to-back recognition reflects Quantiphi's ongoing commitment to excellence.
"Earning a place on the DataTech50 list again, is a testament to our team's relentless focus on delivering impactful data solutions to Banking and Financial Services and Insurance clients globally," Kalita said. "Quantiphi remains dedicated to solving what matters most for enterprise—enabling financial institutions to optimize their data ecosystems, accelerate AI adoption and drive smarter, faster decision-making."
With a proven track record of more than 2,500 AI-led projects across the globe and an estimated $2 billion in business impact, Quantiphi continues to push the boundaries of what's possible in data modernization, AI-powered analytics and compliance-ready solutions tailored for the financial services industry.
About QuantiphiQuantiphi is an award-winning AI-first digital engineering company driven by the desire to reimagine and realize transformational opportunities at the heart of business. Since its inception in 2013, Quantiphi has solved the toughest and most complex business problems by combining deep industry experience, disciplined cloud and data engineering practices, and cutting-edge artificial intelligence research to achieve accelerated and quantifiable business results. Learn more at Quantiphi.com and follow us on Linkedin, X, formerly Twitter and Instagram.
About DataTech50The DataTech50 is an annual list by FinTech Global recognizing the 50 most innovative technology companies offering data management solutions to financial services organizations. The list serves as a definitive resource for financial institutions seeking to advance their digital transformation and data management strategies.
Media Contact:
H. Mayes
contact.newsroom@quantiphi.com
Quantiphi Newsroom
View original content to download multimedia:https://www.prnewswire.com/news-releases/quantiphi-recognized-on-datatech50-list-for-second-consecutive-year-for-leadership-in-data-management-solutions-302462262.html
SOURCE Quantiphi
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
30 minutes ago
- Yahoo
Phoenix Star Insurance Agency Partners with Integrity to Transform Access to Medicare Coverage in Underserved Communities
Service and growth opportunities abound for multilingual agency as it leverages Integrity's advanced technology, compliance support and innovative resources DALLAS, June 13, 2025 /PRNewswire/ -- Integrity, LLC ("Integrity"), a leading distributor of life and health insurance, and provider of wealth management and retirement planning solutions, today announced it has partnered with Phoenix Star Insurance Agency, an independent marketing organization based in Garden Grove, California, and led by Allan Ly and Cindy Kien. Financial details of the partnership were not disclosed. "Allan and Cindy have a deep-rooted passion for making a meaningful difference in the lives of others, especially those in underserved communities," said Bryan W. Adams, Co-Founder and CEO of Integrity. "Integrity is equally focused on improving lives by helping more Americans from all walks of life access the insurance and retirement planning solutions they truly need. As an Integrity partner, Phoenix Star Insurance Agency can streamline its operations, expand its reach and continue delivering the highest quality of service to diverse communities, especially through their multilingual offerings. It's an honor to partner with dedicated professionals whose work is a reflection of their compassion and core values. We couldn't be more excited about the future we're building together!" As first-generation Vietnamese immigrants, Ly and Kien bring a profound affinity and appreciation for the diverse communities they serve. The agency's multilingual team specializes in delivering Medicare products to the dual-eligible market, offering deep expertise and efficient service to clients across 20 states. The unwavering support and guidance Ly and Kien provide to Phoenix Star agents through mentorship programs and ongoing training has led to increased success rates and notably low attrition. Phoenix Star Insurance Agency is also a dedicated contributor to community programs that offer support, guidance and education to immigrants and families. "At Phoenix Star Insurance Agency, we are building up our local community by bringing services specifically to overlooked and underserved populations," explained Allan Ly, CEO of Phoenix Star Insurance Agency. "Our hard-working agents speak a total of 21 languages and are committed to connecting our clients with the right health insurance to significantly impact their quality of life. Partnering with Integrity offers us cutting-edge technology, essential compliance resources and pivotal support services that will make a real impact on our agents' workflow. Every part of Integrity is designed to help us best use our resources and optimize our processes, empowering us to serve even more people. I'm proud to become part of the Integrity family and can't wait for the evolution and experiences ahead." "Many members of our diverse team can closely relate to the challenges — and opportunities — their clients are experiencing," explained Cindy Kien, CFO of Phoenix Star Insurance Agency. "Our unique perspective means we know how to properly support both agents and clients, while treating everyone we serve with the utmost respect. Integrity shows that same commitment in the way it values its partners, employees, agents and clients, which makes this partnership a perfect alignment of goals and values. We can now leverage the Integrity platform to further develop our agents, expand our impact and manage our book of business more effectively. We're excited for what this partnership holds, and we look forward to improving the lives of countless families together." Developed by forward-thinking experts, Integrity's technology platform facilitates stronger client relationships through efficient processes and proprietary resources. Agents gain access to a consolidated overview of policies with instantaneous quoting and enrollment features and streamlined plan management. This technology fully integrates with Ask IntegrityⓇ, an AI-powered, voice-activated solution that creates personalized connections through in-the-moment prompts, coverage recommendations and policy lifecycle reminders. Integrity partners can also utilize exceptional resources to guide their growth, including access to powerful data and analytics, impactful leadership guidance and ongoing innovation. Integrity's broad-based collective of industry leaders are collaborating to expand access to insurance and financial services for all demographics. These trailblazers and icons are building solutions that facilitate more holistic life, health and wealth coverage and can benefit all consumers. By combining the best practices and world-class leadership experience of Integrity's partner network with its full-stack platform, agents and advisors are helping the individuals and families they serve better plan for the good days ahead. For more information about Phoenix Star Insurance Agency's decision to partner with Integrity, view a video at About IntegrityIntegrity, headquartered in Dallas, Texas, is a leading distributor of life and health insurance, and provider of innovative solutions for wealth management and retirement planning. Through its broad partner network of agents and advisors, Integrity helps millions of Americans protect their life, health and wealth with a commitment to meet them wherever they are — in person, over the phone and online. Integrity's proprietary, cutting-edge technology helps expand the insurance and financial planning experience for all stakeholders using an omnichannel approach. In addition, Integrity develops products with carrier partners and markets them compliantly through its nationwide distribution network. Providing best-in-class service to their clients and consumers is at the center of Integrity's holistic approach to life, health and wealth protection. The company and its partners focus on helping families and individuals prepare for the good days ahead, so they can make the most of what life brings. The recipient of nationally ranked business awards, including Newsweek's America's Greatest Workplaces, Inc.'s Power Partner, and Business Intelligence Group's AI Excellence Award, Integrity has also earned impressive employee sentiment awards such as Best Company for Career Growth, Best Company Leadership, Best Company Culture, and Best Company Happiness. For more information, visit About Phoenix Star Insurance AgencyPhoenix Star Insurance Agency is headquartered in Garden Grove, California, and has specialized in helping clients navigate Medicare since 2009. The agency is known and respected for its focus on providing personalized solutions that meet the unique needs of individuals. In addition, Phoenix Star agents and staff are continually trained to help ensure clients receive reliable coverage and trusted support. With access to an extensive array of insurance carriers and plans, Phoenix Star can tailor solutions to the diverse needs of each client and help them maximize the benefits they've earned. View original content to download multimedia: SOURCE Integrity Marketing Group, LLC Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
30 minutes ago
- Yahoo
Air Products to Showcase Industrial Gas Solutions at the PowderMet2025 International Conference on Powder Metallurgy and Particulate Materials
LEHIGH VALLEY, Pa., June 13, 2025 /PRNewswire/ -- Air Products (NYSE:APD) will showcase industrial gas solutions and technologies for metals and materials processing applications at the PowderMet2025 International Conference on Powder Metallurgy and Particulate Materials from June 15-18 at the Sheraton Phoenix Downtown in Phoenix, Arizona. Those attending are invited to stop by Air Products' booth #412 to speak with an industry specialist and learn how Air Products' industrial gases, technologies, and supply solutions can help metal processors improve product quality, reduce operating costs, increase production and optimize gas usage. Air Products' Smart Technology intelligent systems can help take the guesswork out of sintering, annealing, brazing, hot isostatic pressing, metal injection molding and 3D printing. In addition, Reed Hendershot, an Air Products' Senior Engineer, Advanced Technology, will host a technical session titled "Smart Solutions to Improve Sintering Atmosphere and Process" at 3:45 p.m. MST on Monday, June 16. PowderMet2025 is the leading technical conference on powder metallurgy and particulate materials in the Americas and a hub for technology transfer for professionals from every part of the industry, including buyers and specifiers of metal powders, tooling and compacting presses, sintering furnaces, furnace belts, powder handling and blending equipment, quality-control and automation equipment, particle-size and powder-characterization equipment, consulting and research services. For more than 50 years, metals processors around the world have relied on Air Products' industrial gases, gas atmospheres, equipment and technical support. Air Products provides industrial gases including nitrogen, oxygen, argon, helium and hydrogen, gas handling equipment and technology, additives, global supply capability and unmatched industry experience and technical know-how to help organizations succeed. For more information on how Air Products' industrial gases and expertise can assist metals and materials processors visit Air Products' Metals Processing Knowledge Center. About Air Products Air Products (NYSE: APD) is a world-leading industrial gases company in operation for over 80 years focused on serving energy, environmental, and emerging markets and generating a cleaner future. The Company supplies essential industrial gases, related equipment and applications expertise to customers in dozens of industries, including refining, chemicals, metals, electronics, manufacturing, medical and food. As the leading global supplier of hydrogen, Air Products also develops, engineers, builds, owns and operates some of the world's largest clean hydrogen projects, supporting the transition to low- and zero-carbon energy in the industrial and heavy-duty transportation sectors. Through its sale of equipment businesses, the Company also provides turbomachinery, membrane systems and cryogenic containers globally. Air Products had fiscal 2024 sales of $12.1 billion from operations in approximately 50 countries and has a current market capitalization of over $60 billion. For more information, visit or follow us on LinkedIn, X, Facebook or Instagram. View original content: SOURCE Air Products Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
38 minutes ago
- Yahoo
Revolutionizing Diagnostics: Digital Pathology Market Growth Report Reach US$1.73 billion by 2030 at 8.0% CAGR
CHICAGO, June 13, 2025 /PRNewswire/ -- The Global Digital Pathology Market is projected to be valued at USD 1.10 billion in 2024 and reach USD 1.73 billion by 2030, growing at a CAGR of 8% according to a new report by The Research Insights. The key driver of this growth is the mounting need for telepathology to enable pathologists to remotely view slides and interact live over distances. The other factor is integrating artificial intelligence (AI) in digital pathology systems, boosting diagnostics through automated image analysis and predictive analytics. The report runs an in-depth analysis of market trends, key players, and future opportunities. In general, the Digital Pathology Market growth of 8.0% comprises a vast array of Product, Type, Application, End-Use, and Geography which are expected to register strength during the coming years. For More Information and To Stay Updated on The Latest Developments in The Global Digital Pathology Market, Download FREE Sample Pages: Market Overview and Growth Trajectory: Digital Pathology Market Growth: According to an exhaustive report by The Research Insights, the Digital Pathology Market is experiencing significant growth. The worldwide digital pathology market expansion results from multiple technological advancements alongside clinical and systemic changes that mirror a comprehensive shift in diagnostic methods and healthcare service delivery. The rapid integration of artificial intelligence (AI) and machine learning algorithms serves as a key driving force in pathology because they improve diagnostic accuracy while enhancing workflow efficiency and decision-making support. Precision medicine's rising requirement along with individually tailored treatment plans drives the need for digital platforms that integrate histopathological data with genomic and clinical information. The worldwide scarcity of pathologists in developing markets forces healthcare infrastructures to implement digital pathology systems that consolidate diagnostic capabilities and allow for remote consultations through telepathology. The global rise in cancer cases demands the development of diagnostic solutions that operate more quickly and can scale to meet increasing needs. The FDA's regulatory approvals and standardization efforts are helping to validate digital pathology systems which leads to their broader use. The focus on digital health infrastructure and remote healthcare solutions after COVID-19 has solidified digital pathology's essential role in modern diagnostic processes. Rising Prevalence of Chronic Diseases and Cancer:The increasing global prevalence of chronic illnesses such as cancer alongside cardiovascular and autoimmune diseases creates demand for digital pathology through the need for accurate diagnostic results. Cancer stands as a primary focus area because the World Health Organization (WHO) reports that it causes almost 10 million deaths each year. The growing number of cancer cases increases the need for precise histopathological assessments which play a critical role in cancer staging and treatment planning as well as determining patient glass-slide microscopy requires extensive time commitment while demanding substantial labor effort and remains susceptible to mistakes by human operators. Digital pathology allows for complete slide digitization which supports storage capabilities as well as analysis and sharing functions. Digital platforms play an essential role in oncology and chronic disease management through improved diagnostic accuracy and simpler access to second opinions and telepathology. The requirement for high-throughput pathology services becomes even stronger when centralized laboratories need to serve extensive populations. For Detailed Market Insights, Visit: Innovations in Whole Slide Imaging (WSI) technology combined with artificial intelligence (AI) integration are driving major changes in digital pathology:Progress in imaging technology alongside improvements in data storage and artificial intelligence (AI) development is revolutionizing digital pathology. The development of Whole Slide Imaging (WSI) now enables the capture of ultra-high-resolution images which can be stored and distributed with very little delay. After digitization these images become suitable for AI analysis which helps detect patterns and anomalies while classifying tissue types with greater consistency than manual workflows now frequently utilize AI-powered tools to help pathologists identify diseases at early stages while simultaneously quantifying biomarkers and standardizing interpretations. The algorithms designed for breast and prostate cancer detection improve diagnostic efficiency and minimize inter-observer variability by highlighting suspicious regions and providing grading suggestions. Real-time slide sharing capabilities of cloud-based platforms allow institutions to collaborate on diagnostics without being limited by geographic distances. This technological progress improves diagnostic speed and accuracy while shortening turnaround time which is essential for treating life-threatening conditions. Growing Adoption of Telepathology and Remote Consultations:The pandemic hastened digital health technology implementation with digital pathology becoming another beneficiary of this trend. Telepathology has become an essential diagnostic tool due to increasing demands for remote consultations and second opinions. Digital platforms now enable hospitals and laboratories to share slides across regions and countries with specialists which allows for expert reviews and collaborations to occur promptly without needing to transport specimens is emerging as a critical solution to the worldwide inequality in pathology services. Rural regions and areas with limited resources experience a significant lack of trained pathologists. Through digital pathology centralized specialists review cases from distant locations which closes existing healthcare gaps to advance healthcare equity. Digital pathology platforms provide educational institutions with benefits for training and research because students and researchers can access actual slides from any location at any time. Stay Updated on The Latest Digital Pathology Market Trends: Geographical Insights: The North American market achieved a 40.7% share of the global market in 2023 because government-backed initiatives advanced pathology technology. The dominance resulted from continuous R&D funding and the growing implementation of digital imaging technologies. Their influence grew stronger in the region because prominent players focused on creating innovative solutions to meet the needs of the local population. Market expansion is propelled by academic research and disease diagnosis needs for digital pathology because institutions aim to use its capabilities to enhance diagnostic accuracy and treatment results. Between 2024 and 2030 the Asia Pacific region will achieve the highest Compound Annual Growth Rate (CAGR) thanks to increased digitalization activities combined with medical research investments and the growing use of digital imaging technologies in developing economies. The rising occurrence of cancer cases continues to drive market growth which highlights the necessity for new treatment options that will advance market expansion. Global Digital Pathology Market Segmentation and Geographical Insights: Based on Product, the digital pathology market is divided into, Software, Device, and Storage System. The device segment dominated the market share in 2023 with 51.72% and is expected to experience substantial growth over the projected period. Based on Type, the digital pathology market is divided into, Human Pathology, and Veterinary Pathology. The human aspect of digital pathology is playing a pivotal role, accounting for approximately 60.0% market share in 2023. Based on Application, the digital pathology market is divided into, Drug Discovery & Development, Academic Research, and Disease Diagnosis. The academic research segment led the market share in 2023, accounting for 45.7%, and is expected to continue its dominance from 2024 to 2030 due to ongoing research in cancer therapy development and high adoption rates of digital pathology in various studies. Based on End Use, the digital pathology market is divided into, Hospitals, Biotech & Pharma Companies, Diagnostic Labs, and Academic & Research Institutes. The healthcare sector led the market share in 2023 with a notable presence of 36.7%. The Digital Pathology Market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Purchase Premium Copy of Global Digital Pathology Market Size and Growth Report (2024-2030) at: Key Players and Competitive Landscape: The Global Digital Pathology Market is characterized by the presence of several major players, including: Leica Biosystems Nussloch GmbH (Danaher) Hamamatsu Photonics, Inc. Koninklijke Philips N.V. Olympus Corporation F. Hoffmann-La Roche Ltd. Mikroscan Technologies, Inc. Inspirata, Inc. Epredia (3DHISTECH Ltd.) Visiopharm A/S Huron Technologies International Inc. ContextVision AB CellaVision HANGZHOU ZHIWEI INFORMATION TECHNOLOGY CO. LTD. (MORPHOGO) West Medica Produktions- und Handels- GmbH (West Medica) aetherAI IBEX (IBEX MEDICAL ANALYTICS) SigTuple Technologies Private Limited Morphle Labs, Inc Bionovation Biotech, Inc. These companies are adopting strategies such as new product launches, joint ventures, and geographical expansion to maintain their competitive edge in the market. Global Digital Pathology Market Recent Developments and Innovations: In March 2024: Koninklijke Philips N.V. (Netherlands) formed an expanded partnership with AWS to create secure, scalable cloud-based digital pathology solutions. The collaboration between AWS and Philips will improve workflow efficiency while ensuring smooth integration with current healthcare systems to provide complete patient care. In February 2024: Roche entered into a partnership with Path AI to build an AI-powered digital pathology algorithm for companion diagnostics. Through this partnership Roche will speed up its capacity to fulfill biopharma companies' needs who seek to create AI-driven companion diagnostics and deliver complete solutions. In March 2023: Agilent Technologies partnered with Hamamatsu Photonics K.K. Agilent Technologies teamed up with Hamamatsu Photonics K.K. to integrate the NanoZoomer range with the S360MD Slide scanner system into their comprehensive digital pathology solution. In March 2022: Roche Diagnostics partnered with SRL Diagnostics. In collaboration with Roche Diagnostics, SRL Diagnostics intended to upgrade its Fortis Memorial Research Institute laboratory facilities. For Region-Specific Market Data, Check Out Brief Sample Pages: Frequently Asked Questions (FAQs): What is the forecasted market size of the Digital Pathology Market in 2030? The forecasted market size of the Digital Pathology Market is USD 1.73 billion in 2030. Who are the leading players in the Digital Pathology Market? The key players in the Digital Pathology Market include, Leica Biosystems Nussloch GmbH (Danaher); Hamamatsu Photonics, Inc.; Koninklijke Philips N.V.; Olympus Corp.; F. Hoffmann-La Roche Ltd.; Mikroscan Technologies, Inc.; Inspirata, Inc.; Epredia (3DHISTECH Ltd.); Visiopharm A/S; Huron Technologies International Inc.; ContextVision AB; HANGZHOU ZHIWEI INFORMATION TECHNOLOGY CO. LTD. (MORPHOGO); West Medica Produktions- und Handels- GmbH (West Medica); aetherAI; IBEX (IBEX MEDICAL ANALYTICS); SigTuple Technologies Private Limited; Morphle Labs, Inc; and Bionovation Biotech, Inc. What are the major drivers for the Digital Pathology Market? Several key factors are driving this expansion, including the growing adoption of AI-enabled digital pathology. Which is the largest region during the forecasted period in the Digital Pathology Market? The North American market achieved a 40.7% share of the global market in 2023 because government-backed initiatives advanced pathology technology. Which is the largest segment, by product, during the forecasted period in the Digital Pathology Market? The device segment dominated the market share in 2023 with 51.72% and is expected to experience substantial growth over the projected period. Conclusion: Digital imaging advancements and AI along with data analytics improvements lead to major transformations within the global digital pathology market which meets healthcare systems' needs for swifter and more precise diagnostic procedures. The spread of chronic diseases combined with telepathology demand growth and pathologist workforce deficits has sped up the implementation of digital pathology technologies. Modern systems provide the ability for immediate remote medical consultations alongside more efficient data exchange and better-informed decisions through artificial intelligence that analyses medical images. The combination of EHR integration with advanced interoperability and cloud storage solutions leads to better diagnostic precision and operational efficiency. Digital pathology stands as a fundamental component of precision medicine and laboratory automation while global healthcare digitization progresses alongside evolving regulatory frameworks and advanced data security technologies. The market's growth momentum continues as it connects with wider digital health movements and shifts towards value-based care approaches. Need A Diverse Region or Sector? Customize Research to Suit Your Requirement: The report from The Research Insights, therefore, provides several stakeholders—healthcare providers, diagnostic laboratories, research institutions, pharmaceutical companies, and regulatory agencies—with valuable insights into how to successfully navigate this evolving market landscape and unlock new opportunities. With projected growth to US$ 1.73 billion by 2030, the Global Digital Pathology Market represents a significant opportunity for AI technology developers, cloud service providers, medical imaging software companies, digital health startups, and telepathology platform vendors. Check out more related studies published by The Research Insights: U.S. And Europe Digital Pathology Market - The US and European digital pathology market is poised for significant growth, driven by increasing efforts to harness this technology for enhanced disease diagnosis and improved pathology practices. Currently valued at USD 578.6 million in 2022, the market is projected to expand at a compound annual growth rate (CAGR) of 7.2% from 2023 to 2030. In the US, the FDA has classified digital pathology as Class II devices suitable for primary diagnosis, paving the way for wider adoption. Pathology Laboratories Market: The Global Pathology Laboratories Market is expected to reach at USD 612.22 billion by 2030, according to a new report by The Research Insights. It is projected to expand at a CAGR of 8.1% during the forecast period. This growth is driven by the expanding healthcare infrastructure in developing countries, as well as an increasing demand for regular medical check-ups and enhanced reimbursement policies for diagnostic tests. AI in Pathology Market - The AI in Pathology Market size is set to grow from USD 92.32 million in 2025 to USD 434.16 million by 2034, at a CAGR of 19.07%. The AI for Pathology Market describes how artificial intelligence technologies including machine learning algorithms and neural networks process pathology data to aid clinical decision-making while boosting diagnostic precision and workflow productivity. The medical field of pathology which focuses on disease study and diagnosis through tissue, organ, and fluid examination is experiencing a digital shift through AI integration. Anatomic Pathology Market - The global anatomic pathology market continues to expand its reach, with valued sales reaching USD 30.16 billion in 2022. As we look ahead, the market is projected to experience a significant compound annual growth rate (CAGR) of 8.7% from 2023 to 2030. This surge in growth can be attributed to the increasing adoption of biomarkers in clinical settings, which has revolutionized the way pathologists analyze molecular-level mechanisms. Precision Pathology for Cancer Market: The Research Insights report reveals that Precision pathology for cancer applies advanced technological methods to produce customized diagnostic and therapeutic approaches based on individual tumor biology. This innovative method combines histological, genomic and bioinformatic knowledge to enable healthcare providers to develop individualized treatment plans which lead to improved patient results. Browse More related reports on Healthcare Industry Market Reports – About Us: The Research Insights provides thoroughly conducted research which is backed up by real-time statistics and data. Our experts are eager to help you with any information required under the sun. The key to our success is keeping abreast with the markets, industries, and ever-changing consumer trends that matter. Our market research professionals have in-depth knowledge and expertise across various domains that includes IT and Telecom, Emerging Technologies, Consumer Offerings, Manufacturing and Others. We are committed to reviewing the scope and procedure of the research studies that you select and provide you with an accurate guidance in order to assist you in taking the correct business decisions. Contact Us:If you have any queries about this report or if you would like further information, please contact us: Contact Person: Kaushik RoyE-mail: sales@ +1-312-313-8080Blog: Release: News: | Logo: View original content: SOURCE The Research Insights
